Peter N. Morcos
Impact in
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Brain Metastases and Treatment
- Lung Cancer Diagnosis and Treatment
- Oncology top 1%
- Lung Cancer Research Studies
Papers in
-
- Lung Cancer Treatments and Mutations 34
- Oncology 29
- Lung Cancer Research Studies 11
- CAR-T cell therapy research 10
- Colorectal Cancer Treatments and Studies 6
- Co-authors
- Sai‐Hong Ignatius Ou (10 shared papers)Bogdana Balas (17 shared papers)Sophie Golding (9 shared papers)Shirish M. Gadgeel (8 shared papers)Ali Zeaiter (16 shared papers)Jin Seok Ahn (7 shared papers)Alice T. Shaw (10 shared papers)Dong‐Wan Kim (6 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)Blood (6 papers)Cancer Chemotherapy and Pharmacology (4 papers)Annals of Oncology (4 papers)Clinical and Translational Science (4 papers)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Peter N. Morcos
81 papers receiving 4.2k citations
Peter N. Morcos's Hit Papers
Peers
Comparison fields: 5 of 101
- Pulmonary and Respiratory Medicine 2.7k
- Oncology 1.9k
- Hepatology 375
- Cancer Research 446
- Genetics 283
Countries citing papers authored by Peter N. Morcos
This map shows the geographic impact of Peter N. Morcos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter N. Morcos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter N. Morcos more than expected).
Fields of papers citing papers by Peter N. Morcos
This network shows the impact of papers produced by Peter N. Morcos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter N. Morcos. The network helps show where Peter N. Morcos may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter N. Morcos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer Hit paper breakdown → | 2017 | 1651 |
| 2 | Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study Hit paper breakdown → | 2014 | 541 |
| 3 | Alectinib in Crizotinib-Refractory ALK-Rearranged Non–Small-Cell Lung Cancer: A Phase II Global Study Hit paper breakdown → | 2015 | 430 |
| 4 | 2010 | 240 | |
| 5 | 2019 | 187 | |
| 6 | 2008 | 72 | |
| 7 | 2017 | 66 | |
| 8 | 2016 | 63 | |
| 9 | 2016 | 54 | |
| 10 | 2009 | 41 | |
| 11 | 2016 | 40 | |
| 12 | 2016 | 38 | |
| 13 | 2017 | 36 | |
| 14 | 2013 | 34 | |
| 15 | 2017 | 33 | |
| 16 | 2017 | 26 | |
| 17 | 2012 | 26 | |
| 18 | 2018 | 25 | |
| 19 | 2019 | 24 | |
| 20 | 2018 | 24 |
About Peter N. Morcos
Peter N. Morcos is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Epidemiology and Hepatology, having authored 86 papers that have together received 4.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (34 papers), Lung Cancer Research Studies (11 papers), CAR-T cell therapy research (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Hepatitis C virus research (9 papers), Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (8 papers) and Colorectal Cancer Treatments and Studies (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.7k citations), Oncology (1.9k citations), Hepatology (375 citations), Cancer Research (446 citations) and Genetics (283 citations). Peter N. Morcos has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Sai‐Hong Ignatius Ou, Bogdana Balas, Sophie Golding, Shirish M. Gadgeel, Ali Zeaiter, Jin Seok Ahn, Alice T. Shaw, Dong‐Wan Kim, Rafał Dziadziuszko and Johannes Noé. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cancer Chemotherapy and Pharmacology, Annals of Oncology and Clinical and Translational Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.